Skip to content
PubMed This is a summary of 106 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 106 referenced papers

Top Authors

Henrik Falhammar
Karolinska University Hospital
Richard J. Auchus
University of California, San Francisco
Deborah P. Merke
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Peter A. Lee
Penn State Milton S. Hershey Medical Center
Selma F. Witchel
Children's Hospital of Pittsburgh
Eystein S. Husebye
Haukeland University Hospital
Walter L. Miller
University of California, San Francisco
David J. Torpy
Royal Adelaide Hospital
Anna Nordenström
Pediatrics and Genetics
Adina F. Turcu
University of Michigan

Top Institutions

Ranked by publications Top 10 institutions
04
06

Eunice Kennedy Shriver National Institute of Child Health and Human Development

Bethesda, United States

64 papers

References

References (106)
  1. 1

    Adrenal steroidogenesis and congenital adrenal hyperplasia.

    Turcu AF, Auchus RJ

    Endocrinology and metabolism clinics of North America 2015; (44(2)):275-96.

    PMID: 26038201
  2. 2

    Blood Pressure in a Large Cohort of Children and Adolescents With Classic Adrenal Hyperplasia (CAH) Due to 21-Hydroxylase Deficiency.

    Bonfig W, Roehl FW, Riedl S, et al.

    American journal of hypertension 2016; (29(2)):266-72 doi:10.1093/ajh/hpv087.

    PMID: 26071487
  3. 3

    Hormonal circadian rhythms in patients with congenital adrenal hyperplasia: identifying optimal monitoring times and novel disease biomarkers.

    Debono M, Mallappa A, Gounden V, et al.

    European journal of endocrinology 2015; (173(6)):727-37 doi:10.1530/EJE-15-0064.

    PMID: 26340969
  4. 4

    Timing and Outcome Concerns regarding Feminizing Genitoplasty from the Perspective of Egyptian Families of Girls with Virilized External Genitalia.

    Marei MM, Fares AE, Musa N, et al.

    Hormone research in paediatrics 2016; (85(1)):49-57 doi:10.1159/000442200.

    PMID: 26645541
  5. 5

    Experience in optimizing fertility outcomes in men with congenital adrenal hyperplasia due to 21 hydroxylase deficiency.

    King TF, Lee MC, Williamson EE, Conway GS

    Clinical endocrinology 2016; (84(6)):830-6 doi:10.1111/cen.13001.

    PMID: 26666213
  6. 6

    Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline.

    Bornstein SR, Allolio B, Arlt W, et al.

    The Journal of clinical endocrinology and metabolism 2016; (101(2)):364-89 doi:10.1210/jc.2015-1710.

    PMID: 26760044
  7. 7

    The experience of women living with Congenital Adrenal Hyperplasia: impact of the condition and the care given.

    Engberg H, Möller A, Hagenfeldt K, et al.

    Clinical endocrinology 2016; (85(1)):21-8 doi:10.1111/cen.13054.

    PMID: 26941069
  8. 8

    Clinical Role of CYP2C19 Polymorphisms in Patients with Congenital Adrenal Hyperplasia Due to 21-hydroxylase Deficiency.

    Grošelj U, Žerjav Tanšek M, Trebušak Podkrajšek K, et al.

    Acta chimica Slovenica 2016; (63(1)):33-7 doi:10.17344/acsi.2015.1797.

    PMID: 26970786
  9. 9

    Diagnosis and treatment of adrenal insufficiency including adrenal crisis: a Japan Endocrine Society clinical practice guideline [Opinion].

    Yanase T, Tajima T, Katabami T, et al.

    Endocrine journal 2016; (63(9)):765-784 doi:10.1507/endocrj.EJ16-0242.

    PMID: 27350721
  10. 10

    Steroid 21-hydroxylase deficiency in congenital adrenal hyperplasia.

    Parsa AA, New MI

    The Journal of steroid biochemistry and molecular biology 2017; (165(Pt A)):2-11 doi:10.1016/j.jsbmb.2016.06.015.

    PMID: 27380651
  11. 11

    Testicular Adrenal Rest Tumors in Boys and Young Adults with Congenital Adrenal Hyperplasia.

    Kim MS, Goodarzian F, Keenan MF, et al.

    The Journal of urology 2017; (197(3 Pt 2)):931-936 doi:10.1016/j.juro.2016.09.072.

    PMID: 27840017
  12. 12

    Neonatal 17-hydroxyprogesterone levels adjusted according to age at sample collection and birthweight improve the efficacy of congenital adrenal hyperplasia newborn screening.

    Hayashi GY, Carvalho DF, de Miranda MC, et al.

    Clinical endocrinology 2017; (86(4)):480-487 doi:10.1111/cen.13292.

    PMID: 27978607
  13. 13

    Management issues of congenital adrenal hyperplasia during the transition from pediatric to adult care.

    Choi JH, Yoo HW

    Korean journal of pediatrics 2017; (60(2)):31-37 doi:10.3345/kjp.2017.60.2.31.

    PMID: 28289431
  14. 14

    Quality of compounded hydrocortisone capsules used in the treatment of children.

    Neumann U, Burau D, Spielmann S, et al.

    European journal of endocrinology 2017; (177(2)):239-242.

    PMID: 28512133
  15. 15

    Congenital adrenal hyperplasia.

    El-Maouche D, Arlt W, Merke DP

    Lancet (London, England) 2017; (390(10108)):2194-2210 doi:10.1016/S0140-6736(17)31431-9.

    PMID: 28576284
  16. 16

    The Key to Adrenal Insufficiency Education: Repetition, Repetition, Repetition.

    Keil MF, Van Ryzin C

    Pediatric endocrinology reviews : PER 2017; (14(Suppl 2)):448-453 doi:10.17458/per.vol14.2017.kr.keyadrenalinsufficiency.

    PMID: 28647949
  17. 17

    Cognitive impairment in adolescents and adults with congenital adrenal hyperplasia.

    Karlsson L, Gezelius A, Nordenström A, et al.

    Clinical endocrinology 2017; (87(6)):651-659 doi:10.1111/cen.13441.

    PMID: 28771762
  18. 18

    How the Child's Gender Matters for Families Having a Child With Congenital Adrenal Hyperplasia.

    Fleming L, Knafl K, Van Riper M

    Journal of family nursing 2017; (23(4)):516-533 doi:10.1177/1074840717735499.

    PMID: 29046104
  19. 19

    Incidence and Characteristics of Adrenal Crisis in Children Younger than 7 Years with 21-Hydroxylase Deficiency: A Nationwide Survey in Japan.

    Ishii T, Adachi M, Takasawa K, et al.

    Hormone research in paediatrics 2018; (89(3)):166-171 doi:10.1159/000486393.

    PMID: 29455197
  20. 20

    Longitudinal Assessment of Illnesses, Stress Dosing, and Illness Sequelae in Patients With Congenital Adrenal Hyperplasia.

    El-Maouche D, Hargreaves CJ, Sinaii N, et al.

    The Journal of clinical endocrinology and metabolism 2018; (103(6)):2336-2345 doi:10.1210/jc.2018-00208.

    PMID: 29584889
  21. 21

    MECHANISMS IN ENDOCRINOLOGY: Rare defects in adrenal steroidogenesis.

    Miller WL

    European journal of endocrinology 2018; (179(3)):R125-R141.

    PMID: 29880708
  22. 22

    Mortality in children with classic congenital adrenal hyperplasia and 21-hydroxylase deficiency (CAH) in Germany.

    Dörr HG, Wollmann HA, Hauffa BP, et al.

    BMC endocrine disorders 2018; (18(1)):37 doi:10.1186/s12902-018-0263-1.

    PMID: 29884168
  23. 23

    Variations in the management of acute illness in children with congenital adrenal hyperplasia: An audit of three paediatric hospitals.

    Chrisp GL, Maguire AM, Quartararo M, et al.

    Clinical endocrinology 2018; (89(5)):577-585 doi:10.1111/cen.13826.

    PMID: 30086199
  24. 24

    Growth of patients with congenital adrenal hyperplasia due to 21-hydroxylase in infancy, glucocorticoid requirement and the role of mineralocorticoid therapy.

    Sellick J, Aldridge S, Thomas M, Cheetham T

    Journal of pediatric endocrinology & metabolism : JPEM 2018; (31(9)):1019-1022 doi:10.1515/jpem-2018-0260.

    PMID: 30173205
  25. 25

    Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline.

    Speiser PW, Arlt W, Auchus RJ, et al.

    The Journal of clinical endocrinology and metabolism 2018; (103(11)):4043-4088 doi:10.1210/jc.2018-01865.

    PMID: 30272171
  26. 26

    Introduction: Contemporary perspectives on congenital adrenal hyperplasia: impacts on reproduction.

    New MI, Rosenwaks Z

    Fertility and sterility 2019; (111(1)):4-6 doi:10.1016/j.fertnstert.2018.11.031.

    PMID: 30611412
  27. 27

    Congenital adrenal hyperplasia with salt-wasting crisis and arrhythmia: a case study.

    Canlas JF, Ponmani C

    BMJ case reports 2019; (12(1)) doi:10.1136/bcr-2018-227565.

    PMID: 30700462
  28. 28

    Evaluation of the Dutch neonatal screening for congenital adrenal hyperplasia.

    van der Linde AAA, Schönbeck Y, van der Kamp HJ, et al.

    Archives of disease in childhood 2019; (104(7)):653-657 doi:10.1136/archdischild-2018-315972.

    PMID: 30712004
  29. 29

    Review of Health Problems in Adult Patients with Classic Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency.

    Reisch N

    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2019; (127(2-03)):171-177 doi:10.1055/a-0820-2085.

    PMID: 30812049
  30. 30

    Testicular Adrenal Rest Tumors: Current Insights on Prevalence, Characteristics, Origin, and Treatment.

    Engels M, Span PN, van Herwaarden AE, et al.

    Endocrine reviews 2019; (40(4)):973-987 doi:10.1210/er.2018-00258.

    PMID: 30882882
  31. 31

    Height Velocity Defined Metabolic Control in Children With Congenital Adrenal Hyperplasia Using Urinary Steroid GC-MS Analysis.

    Kamrath C, Wettstaedt L, Hartmann MF, Wudy SA

    The Journal of clinical endocrinology and metabolism 2019; (104(9)):4214-4224 doi:10.1210/jc.2019-00438.

    PMID: 31112272
  32. 32

    Update on adrenal steroid hormone biosynthesis and clinical implications.

    Bacila IA, Elder C, Krone N

    Archives of disease in childhood 2019; (104(12)):1223-1228 doi:10.1136/archdischild-2017-313873.

    PMID: 31175123
  33. 33

    The impact of CYP21A2 (P30L/I172N) genotype on female fertility in one family.

    Kocova M, Anastasovska V, Bitovska I

    European journal of medical research 2019; (24(1)):21 doi:10.1186/s40001-019-0379-4.

    PMID: 31217034
  34. 34

    Quantitative targeted GC-MS-based urinary steroid metabolome analysis for treatment monitoring of adolescents and young adults with autoimmune primary adrenal insufficiency.

    Kamrath C, Hartmann MF, Wudy SA

    Steroids 2019; (150()):108426 doi:10.1016/j.steroids.2019.108426.

    PMID: 31228484
  35. 35

    Issues with the Detection of Large Genomic Rearrangements in Molecular Diagnosis of 21-Hydroxylase Deficiency.

    Concolino P

    Molecular diagnosis & therapy 2019; (23(5)):563-567 doi:10.1007/s40291-019-00415-z.

    PMID: 31317337
  36. 36

    Detection of a novel severe mutation affecting the CYP21A2 gene in a Chilean male with salt wasting congenital adrenal hyperplasia.

    Arteaga E, Valenzuela F, Lagos CF, et al.

    Endocrine 2020; (67(1)):258-263 doi:10.1007/s12020-019-02097-3.

    PMID: 31571129
  37. 37

    Bone mineral density and fractures in congenital adrenal hyperplasia: Findings from the dsd-LIFE study.

    Riehl G, Reisch N, Roehle R, et al.

    Clinical endocrinology 2020; (92(4)):284-294 doi:10.1111/cen.14149.

    PMID: 31886890
  38. 38

    Glucocorticoid replacement regimens for treating congenital adrenal hyperplasia.

    Ng SM, Stepien KM, Krishan A

    The Cochrane database of systematic reviews 2020; (3()):CD012517 doi:10.1002/14651858.CD012517.pub2.

    PMID: 32190901
  39. 39

    Genetic characterization of a large cohort of Argentine 21-hydroxylase Deficiency.

    Fernández CS, Taboas M, Bruque CD, et al.

    Clinical endocrinology 2020; (93(1)):19-27 doi:10.1111/cen.14190.

    PMID: 32289882
  40. 40

    The effect of patient-managed stress dosing on electrolytes and blood pressure in acute illness in children with adrenal insufficiency.

    Chrisp GL, Torpy DJ, Maguire AM, et al.

    Clinical endocrinology 2020; (93(2)):97-103 doi:10.1111/cen.14196.

    PMID: 32301148
  41. 41

    An integrated PK-PD model for cortisol and the 17-hydroxyprogesterone and androstenedione biomarkers in children with congenital adrenal hyperplasia.

    Al-Kofahi M, Ahmed MA, Jaber MM, et al.

    British journal of clinical pharmacology 2021; (87(3)):1098-1110 doi:10.1111/bcp.14470.

    PMID: 32652643
  42. 42

    Guidance for the prevention and emergency management of adult patients with adrenal insufficiency.

    Simpson H, Tomlinson J, Wass J, et al.

    Clinical medicine (London, England) 2020; (20(4)):371-378 doi:10.7861/clinmed.2019-0324.

    PMID: 32675141
  43. 43

    A Prospective Study of Children Aged 0-8 Years with CAH and Adrenal Insufficiency Treated with Hydrocortisone Granules.

    Neumann U, Braune K, Whitaker MJ, et al.

    The Journal of clinical endocrinology and metabolism 2021; (106(3)):e1433-e1440 doi:10.1210/clinem/dgaa626.

    PMID: 32888021
  44. 44

    The spectrum of CYP21A2 gene mutations in patients with classic salt wasting form of 2l-hydroxylase deficiency in a Chinese cohort.

    Liu Y, Zheng J, Liu N, et al.

    Molecular genetics & genomic medicine 2020; (8(11)):e1501 doi:10.1002/mgg3.1501.

    PMID: 32959514
  45. 45

    Pregnancy, delivery and neonatal outcomes among women with congenital adrenal hyperplasia: a study of a large US database.

    Badeghiesh A, Ismail S, Baghlaf H, et al.

    Reproductive biomedicine online 2020; (41(6)):1093-1099 doi:10.1016/j.rbmo.2020.08.036.

    PMID: 33008769
  46. 46

    Measurement of 17-Hydroxyprogesterone by LCMSMS Improves Newborn Screening for CAH Due to 21-Hydroxylase Deficiency in New Zealand.

    de Hora MR, Heather NL, Patel T, et al.

    International journal of neonatal screening 2020; (6(1)):6.

    PMID: 33073005
  47. 47

    Corticotropic insufficiency in a monocentric prospective cohort of patients with lung cancer treated with nivolumab: Prevalence and etiology.

    Ducloux R, Tavernier JY, Wojewoda P, et al.

    Annales d'endocrinologie 2021; (82(1)):8-14 doi:10.1016/j.ando.2020.11.010.

    PMID: 33290748
  48. 48

    Nonvirilized Genitalia in 3 Female Newborns With the Salt-Wasting Congenital Adrenal Hyperplasia Phenotype.

    Yauch L, Mayhew A, Gomez-Lobo V, et al.

    Journal of the Endocrine Society 2021; (5(1)):bvaa169 doi:10.1210/jendso/bvaa169.

    PMID: 33294764
  49. 49

    Adrenal insufficiency.

    Husebye ES, Pearce SH, Krone NP, Kämpe O

    Lancet (London, England) 2021; (397(10274)):613-629 doi:10.1016/S0140-6736(21)00136-7.

    PMID: 33484633
  50. 50

    Nonclassic Congenital Adrenal Hyperplasia: What Do Endocrinologists Need to Know?

    Jha S, Turcu AF

    Endocrinology and metabolism clinics of North America 2021; (50(1)):151-165 doi:10.1016/j.ecl.2020.10.008.

    PMID: 33518183
  51. 51

    Semen quality and testicular adrenal rest tumour development in 46,XY congenital adrenal hyperplasia: the importance of optimal hormonal replacement.

    Rohayem J, Bäumer LM, Zitzmann M, et al.

    European journal of endocrinology 2021; (184(4)):487-501.

    PMID: 33524003
  52. 52

    Newborn Screening for CAH-Challenges and Opportunities.

    Heather NL, Nordenstrom A

    International journal of neonatal screening 2021; (7(1)) doi:10.3390/ijns7010011.

    PMID: 33668620
  53. 53

    Adrenal insufficiency.

    Hahner S, Ross RJ, Arlt W, et al.

    Nature reviews. Disease primers 2021; (7(1)):19 doi:10.1038/s41572-021-00252-7.

    PMID: 33707469
  54. 54

    Molecular Analysis of 21-Hydroxylase Deficiency Reveals Two Novel Severe Genotypes in Affected Newborns.

    Concolino P, Paragliola RM

    Molecular diagnosis & therapy 2021; (25(3)):327-337 doi:10.1007/s40291-021-00520-y.

    PMID: 33710594
  55. 55

    Hydrocortisone dosing in children with classic congenital adrenal hyperplasia: results of the German/Austrian registry.

    Hoyer-Kuhn H, Huebner A, Richter-Unruh A, et al.

    Endocrine connections 2021; (10(5)):561-569.

    PMID: 33909597
  56. 56

    Congenital Adrenal Hyperplasia-Current Insights in Pathophysiology, Diagnostics, and Management.

    Claahsen-van der Grinten HL, Speiser PW, Ahmed SF, et al.

    Endocrine reviews 2022; (43(1)):91-159 doi:10.1210/endrev/bnab016.

    PMID: 33961029
  57. 57

    Society for Endocrinology UK Guidance on the initial evaluation of a suspected difference or disorder of sex development (Revised 2021).

    Ahmed SF, Achermann J, Alderson J, et al.

    Clinical endocrinology 2021; (95(6)):818-840 doi:10.1111/cen.14528.

    PMID: 34031907
  58. 58

    Birth Weight- or Gestational Age-adjusted Second-tier LCMSMS Cutoffs Improve Newborn Screening for CAH in New Zealand.

    de Hora MR, Heather NL, Webster D, et al.

    The Journal of clinical endocrinology and metabolism 2021; (106(9)):e3390-e3399 doi:10.1210/clinem/dgab383.

    PMID: 34058748
  59. 59

    Two girls with a neonatal screening-negative 21-hydroxylase deficiency requiring treatment with hydrocortisone for virilization in late childhood.

    Onuma S, Fukuoka T, Miyoshi Y, et al.

    Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology 2021; (30(3)):143-148 doi:10.1297/cpe.30.143.

    PMID: 34285457
  60. 60

    Clinical, Etiological and Laboratory Profile of Children with Disorders of Sexual Development (DSD)-Experience from a Tertiary Pediatric Endocrine Unit in Western India.

    Jahagirdar R, Khadilkar V, Deshpande R, Lohiya N

    Indian journal of endocrinology and metabolism 2021; (25(1)):48-53 doi:10.4103/ijem.IJEM_520_20.

    PMID: 34386394
  61. 61

    Testicular adrenal rest tumors in children with congenital adrenal hyperplasia.

    Al-Ghamdi WM, Shazly MA, Al-Agha AE

    Saudi medical journal 2021; (42(9)):986-993 doi:10.15537/smj.2021.42.9.20210257.

    PMID: 34470837
  62. 62

    Screening for testicular adrenal rest tumors among children with congenital adrenal hyperplasia at King Fahad Medical City, Saudi Arabia.

    Huneif MA, Al Mutairi M, AlHazmy ZH, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2022; (35(1)):49-54 doi:10.1515/jpem-2021-0291.

    PMID: 34757702
  63. 63

    A 4-hour Profile of 17-hydroxyprogesterone in Salt-wasting Congenital Adrenal Hyperplasia: Is the Serial Monitoring Strategy Worth the Effort?

    Besci Ö, Erbaş İM, Küme T, et al.

    Journal of clinical research in pediatric endocrinology 2022; (14(2)):145-152 doi:10.4274/jcrpe.galenos.2021.2021-9-17.

    PMID: 34866371
  64. 64

    The utility of annual growth velocity standard deviation scores and measurements of biochemical parameters in long-term treatment monitoring of children with 21-hydroxylase deficiency.

    Ozdemir Dilek S, Turan I, Gurbuz F, et al.

    Hormones (Athens, Greece) 2022; (21(3)):391-397 doi:10.1007/s42000-022-00354-1.

    PMID: 35243601
  65. 65

    Epidemiology and Long-Term Adverse Outcomes in Korean Patients with Congenital Adrenal Hyperplasia: A Nationwide Study.

    Kim JH, Choi S, Lee YA, et al.

    Endocrinology and metabolism (Seoul, Korea) 2022; (37(1)):138-147 doi:10.3803/EnM.2021.1328.

    PMID: 35255606
  66. 66

    Classic and current concepts in adrenal steroidogenesis: a reappraisal.

    Kater CE, Giorgi RB, Costa-Barbosa FA

    Archives of endocrinology and metabolism 2022; (66(1)):77-87.

    PMID: 35263051
  67. 67

    Twenty Years of Neonatal Screening for Congenital Adrenal Hyperplasia in North-Eastern Italy: Role of Liquid Chromatography-Tandem Mass Spectrometry as a Second-Tier Test.

    Cavarzere P, Camilot M, Palma L, et al.

    Hormone research in paediatrics 2022; (95(3)):255-263 doi:10.1159/000524170.

    PMID: 35350013
  68. 68

    Management challenges and therapeutic advances in congenital adrenal hyperplasia.

    Mallappa A, Merke DP

    Nature reviews. Endocrinology 2022; (18(6)):337-352 doi:10.1038/s41574-022-00655-w.

    PMID: 35411073
  69. 69

    How to manage puberty and prevent fertility disorders in men with CAH?

    Claahsen-van der Grinten HL

    Annales d'endocrinologie 2022; (83(3)):186-187 doi:10.1016/j.ando.2022.04.005.

    PMID: 35436502
  70. 70

    Analysis of therapy monitoring in the International Congenital Adrenal Hyperplasia Registry.

    Lawrence N, Bacila I, Dawson J, et al.

    Clinical endocrinology 2022; (97(5)):551-561 doi:10.1111/cen.14796.

    PMID: 35781728
  71. 71

    Toward Improving the Transition of Patients With Congenital Adrenal Hyperplasia From Pediatrics to Adult Healthcare in Japan.

    Takasawa K, Kashimada K

    Frontiers in pediatrics 2022; (10()):936944 doi:10.3389/fped.2022.936944.

    PMID: 35799687
  72. 72

    Salivary 17-Hydroxyprogesterone Levels in Children with Congenital Adrenal Hyperplasia: A Retrospective Longitudinal Study Considering Auxological Parameters.

    Dubinski I, Bechtold S, Bidlingmaier M, et al.

    Hormone research in paediatrics 2023; (96(3)):259-266 doi:10.1159/000526485.

    PMID: 35960318
  73. 73

    Case of Junctional Rhythm in the Setting of Acute Adrenal Insufficiency.

    Patel P, Kelschenbach K

    Cureus 2022; (14(8)):e27605 doi:10.7759/cureus.27605.

    PMID: 36059370
  74. 74

    Testicular Adrenal Rest Tumors in a Patient With Congenital Adrenal Hyperplasia.

    Yu SY, Freed KM

    Cureus 2022; (14(8)):e28350 doi:10.7759/cureus.28350.

    PMID: 36168332
  75. 75

    Syrian females with congenital adrenal hyperplasia: a case series.

    Dehneh N, Jarjour R, Idelbi S, et al.

    Journal of medical case reports 2022; (16(1)):371 doi:10.1186/s13256-022-03609-y.

    PMID: 36242011
  76. 76

    The management of congenital adrenal hyperplasia during preconception, pregnancy, and postpartum.

    Maher JY, Gomez-Lobo V, Merke DP

    Reviews in endocrine & metabolic disorders 2023; (24(1)):71-83 doi:10.1007/s11154-022-09770-5.

    PMID: 36399318
  77. 77

    Electrolyte abnormalities and stress dosing predict illness-related hospitalizations among infants and toddlers with congenital adrenal hyperplasia.

    Tseng T, Seagroves A, Tanawattanacharoen VK, et al.

    Clinical endocrinology 2023; (98(4)):536-542 doi:10.1111/cen.14876.

    PMID: 36593179
  78. 78

    Congenital adrenal hyperplasia: New biomarkers and adult treatments.

    Dreves B, Reznik Y, Tabarin A

    Annales d'endocrinologie 2023; (84(4)):472-480 doi:10.1016/j.ando.2023.01.008.

    PMID: 36842612
  79. 79

    Acute Gastroenteritis Induced Adrenal Crisis in a patient with Congenital Adrenal Hyperplasia: A Case Report.

    Chapagain N, Adhikari A, Adhikari N, et al.

    JNMA; journal of the Nepal Medical Association 2023; (61(257)):84-86 doi:10.31729/jnma.7926.

    PMID: 37203925
  80. 80

    Impact of Newborn Screening on Adult Height in Patients With Congenital Adrenal Hyperplasia (CAH).

    Hoyer-Kuhn H, Eckert AJ, Binder G, et al.

    The Journal of clinical endocrinology and metabolism 2023; (108(11)):e1199-e1204 doi:10.1210/clinem/dgad307.

    PMID: 37256841
  81. 81

    Screening for Anxiety and Depression in Children with Congenital Adrenal Hyperplasia

    Jacob M, Lin-Su K, Catarozoli C, et al.

    Journal of clinical research in pediatric endocrinology 2023; (15(4)):406-416 doi:10.4274/jcrpe.galenos.2023.2023-2-10.

    PMID: 37470306
  82. 82

    Caring for Patients With Congenital Adrenal Hyperplasia Throughout the Lifespan.

    Zwayne N, Chawla R, van Leeuwen K

    Obstetrics and gynecology 2023; (142(2)):257-268 doi:10.1097/AOG.0000000000005263.

    PMID: 37473408
  83. 83

    Genetic Characterization of a Cohort of Italian Patients with Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency.

    Concolino P, Perrucci A, Carrozza C, Urbani A

    Molecular diagnosis & therapy 2023; (27(5)):621-630 doi:10.1007/s40291-023-00666-x.

    PMID: 37548905
  84. 84

    Testicular adrenal rest tumor in a pediatric patient with congenital adrenal hyperplasia: A case report.

    Ibdah MG, Tos SM, Giacaman N, et al.

    Radiology case reports 2023; (18(11)):4149-4152 doi:10.1016/j.radcr.2023.08.081.

    PMID: 37745756
  85. 85

    The use of liquid chromatography-tandem mass spectrometry in newborn screening for congenital adrenal hyperplasia: improvements and future perspectives.

    de Hora M, Heather N, Webster D, et al.

    Frontiers in endocrinology 2023; (14()):1226284 doi:10.3389/fendo.2023.1226284.

    PMID: 37850096
  86. 86

    Best Practice for Identification of Classical 21-Hydroxylase Deficiency Should Include 21 Deoxycortisol Analysis with Appropriate Isomeric Steroid Separation.

    Greaves RF, Kumar M, Mawad N, et al.

    International journal of neonatal screening 2023; (9(4)) doi:10.3390/ijns9040058.

    PMID: 37873849
  87. 87

    Restoration of reproductive capacity in a male patient with congenital adrenal hyperplasia and bilateral testicular adrenal rest tumors (TARTs) after six months of glucocorticoid intensification: A case report.

    Ahmad J, Ahmad A, Hadid L

    Medicine 2023; (102(49)):e36061 doi:10.1097/MD.0000000000036061.

    PMID: 38065885
  88. 88

    Pregnancy management of IVF-ET pregnancies in a patient with classical 21-hydroxylase deficiency: A case report and review of the literature.

    Yu J, Lu S, Fang L, et al.

    European journal of obstetrics, gynecology, and reproductive biology 2024; (293()):50-56 doi:10.1016/j.ejogrb.2023.12.008.

    PMID: 38104394
  89. 89

    Practice Variation among Pediatric Endocrinologists in the Dosing of Glucocorticoids in Young Children with Congenital Adrenal Hyperplasia.

    Al-Rayess H, Lahoti A, Simpson LL, et al.

    Children (Basel, Switzerland) 2023; (10(12)) doi:10.3390/children10121871.

    PMID: 38136073
  90. 90

    Congenital Adrenal Hyperplasia.

    Fraga NR, Minaeian N, Kim MS

    Pediatrics in review 2024; (45(2)):74-84 doi:10.1542/pir.2022-005617.

    PMID: 38296783
  91. 91

    Diagnosis and management of secondary adrenal crisis.

    Martel-Duguech L, Poirier J, Bourdeau I, Lacroix A

    Reviews in endocrine & metabolic disorders 2024; (25(3)):619-637 doi:10.1007/s11154-024-09877-x.

    PMID: 38411891
  92. 92

    Rare nonclassic type of Congenital adrenal hyperplasia due to 21-hydroxylase deficiency and genotype-phenotypic correlation.

    Hou Y, Li Y, Ai J, Tian L

    Heliyon 2024; (10(5)):e27042 doi:10.1016/j.heliyon.2024.e27042.

    PMID: 38439885
  93. 93

    Phase 3 Trial of Crinecerfont in Pediatric Congenital Adrenal Hyperplasia.

    Sarafoglou K, Kim MS, Lodish M, et al.

    The New England journal of medicine 2024; (391(6)):493-503 doi:10.1056/NEJMoa2404655.

    PMID: 38828945
  94. 94

    Divergent Gender Identity in a Phenotypic Male with 46XX Karyotype Caused by a Mutation in CYP21A2 Gene with Congenital Adrenal Hyperplasia.

    Kumar KCP, Banik S, Joy P, Sahoo S

    International journal of applied & basic medical research 2024; (14(2)):134-137 doi:10.4103/ijabmr.ijabmr_473_23.

    PMID: 38912360
  95. 95

    Adult endocrinologists' perspectives on transitioning adolescent patients with congenital adrenal hyperplasia.

    Hall ME, Kremen J, Boskey ER, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2024; (37(8)):722-729 doi:10.1515/jpem-2024-0158.

    PMID: 39008686
  96. 96

    Long-Read Sequencing Solves Complex Structure of CYP21A2 in a Large 21-Hydroxylase Deficiency Cohort.

    Wang R, Luo X, Sun Y, et al.

    The Journal of clinical endocrinology and metabolism 2025; (110(2)):406-416 doi:10.1210/clinem/dgae519.

    PMID: 39049755
  97. 97

    Metabolic emergencies in the NICU.

    Gupta R, Joshi S, Asghar A, Gray MM

    Seminars in perinatology 2024; (48(8)):151987 doi:10.1016/j.semperi.2024.151987.

    PMID: 39428318
  98. 98

    Comprehensive adolescent healthcare transition program for congenital adrenal hyperplasia: A quality improvement initiative.

    Dennis J, Pitts L, Matalka L, Mays LC

    Health care transitions 2024; (2()):100057 doi:10.1016/j.hctj.2024.100057.

    PMID: 39712594
  99. 99

    Treatment and Follow-up of Congenital Adrenal Hyperplasia Due to 21-hydroxylase Deficiency in Childhood and Adolescence

    Peltek Kendirci HN, Ünal E, Dündar İ, et al.

    Journal of clinical research in pediatric endocrinology 2025; (17(Suppl 1)):12-22 doi:10.4274/jcrpe.galenos.2024.2024-6-26-S.

    PMID: 39713876
  100. 100

    Antenatal Diagnosis and Treatment in Congenital Adrenal Hyperplasia Due to 21-hydroxylase Deficiency and Congenital Adrenal Hyperplasia Screening in Newborns

    Yavaş Abalı Z, Kurnaz E, Güran T

    Journal of clinical research in pediatric endocrinology 2025; (17(Suppl 1)):33-43 doi:10.4274/jcrpe.galenos.2024.2024-6-10-S.

    PMID: 39713885
  101. 101

    Treatment and Prevention of Adrenal Crisis and Family Education

    Çamtosun E, Sangün Ö

    Journal of clinical research in pediatric endocrinology 2025; (17(Suppl 1)):80-92 doi:10.4274/jcrpe.galenos.2024.2024-6-12-S.

    PMID: 39713905
  102. 102

    Clinical Manifestations and Challenges in Adolescent and Adult Females With Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency.

    Engberg H, Nordenström A, Hirschberg AL

    The Journal of clinical endocrinology and metabolism 2025; (110(Supplement_1)):S37-S45 doi:10.1210/clinem/dgae696.

    PMID: 39836618
  103. 103

    Crinecerfont: First Approval.

    Lee A

    Drugs 2025; (85(6)):839-843 doi:10.1007/s40265-025-02165-1.

    PMID: 40240539
  104. 104

    Elective Reconstruction for Children With Congenital Adrenal Hyperplasia: Evaluating Association of Familial Characteristics.

    Heller K, Madura G, Nawara N, et al.

    The Journal of surgical research 2025; (313()):291-296 doi:10.1016/j.jss.2025.06.029.

    PMID: 40680596
  105. 105

    Non-classical congenital adrenal hyperplasia: current insights into clinical implications, diagnosis and treatment.

    Loli P, Menotti S, di Filippo L, Giustina A

    Endocrine 2025; (90(1)):1-16 doi:10.1007/s12020-025-04341-5.

    PMID: 40699527
  106. 106

    Current insights into monitoring of congenital adrenal hyperplasia.

    Leusink QM, Verploegen EEW, Adriaansen BPH, et al.

    Frontiers in endocrinology 2026; (17()):1774145 doi:10.3389/fendo.2026.1774145.

    PMID: 41767372